Sareum (SAR) Competitors GBX 16.65 +0.15 (+0.91%) As of 12:35 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades SAR vs. PHD, IGR, NMT, FEN, CGO, TSI, MYN, IDE, EVG, and MINShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include Proactis (PHD), IG Design Group (IGR), Neometals (NMT), Frenkel Topping Group (FEN), Contango (CGO), Two Shields Investments Plc (TSI.L) (TSI), Mayan Energy (MYN), IDE Group (IDE), Evgen Pharma (EVG), and Minoan Group (MIN). These companies are all part of the "financial services" industry. Sareum vs. Proactis IG Design Group Neometals Frenkel Topping Group Contango Two Shields Investments Plc (TSI.L) Mayan Energy IDE Group Evgen Pharma Minoan Group Sareum (LON:SAR) and Proactis (LON:PHD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment and dividends. Does the MarketBeat Community favor SAR or PHD? Proactis received 91 more outperform votes than Sareum when rated by MarketBeat users. However, 66.13% of users gave Sareum an outperform vote while only 55.10% of users gave Proactis an outperform vote. CompanyUnderperformOutperformSareumOutperform Votes8266.13% Underperform Votes4233.87% ProactisOutperform Votes17355.10% Underperform Votes14144.90% Does the media refer more to SAR or PHD? In the previous week, Sareum's average media sentiment score of 0.00 equaled Proactis'average media sentiment score. Company Overall Sentiment Sareum Neutral Proactis Neutral Is SAR or PHD more profitable? Proactis' return on equity of 0.00% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets SareumN/A -270.25% -113.80% Proactis N/A N/A N/A Which has preferable earnings and valuation, SAR or PHD? Proactis has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than Proactis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSareumN/AN/A-£5.28M-£4.22-3.99Proactis£48.90M0.00N/A-£20.70N/A SummaryProactis beats Sareum on 5 of the 7 factors compared between the two stocks. Remove Ads Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£21.05M£114.95M£5.72B£2.56BDividend Yield1.10%3.69%4.89%4.99%P/E Ratio-3.993.2424.90157.11Price / SalesN/A4,373.64386.10289,438.82Price / Cash11.3213.0138.0528.03Price / Book6.4638.276.924.66Net Income-£5.28M-£87.82M£3.19B£5.73B7 Day Performance2.00%-0.81%-0.77%-0.30%1 Month Performance-15.11%-1.31%-6.78%2.45%1 Year Performance-47.34%100.34%8.03%34.20% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 16.65+0.9%N/A-51.7%£20.80MN/A-3.943,211Gap DownPHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516IGRIG Design Group3.9298 of 5 starsGBX 59.50-1.7%GBX 270+353.8%-50.0%£58.39M£655.48M2.023,092NMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/AFENFrenkel Topping GroupN/AGBX 32.70-0.9%N/A-33.8%£40.06M£34.56M38.10307High Trading VolumeCGOContangoN/AGBX 0.96-4.5%N/A-38.2%£6.90MN/A-95.502,219Positive NewsGap DownTSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053MYNMayan EnergyN/AN/AN/AN/A£5.28M£-3,000.00-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010MINMinoan GroupN/AGBX 0.36-5.1%N/A-51.7%£3.31MN/A-3.468Gap Down Remove Ads Related Companies and Tools Related Companies Proactis Competitors IG Design Group Competitors Neometals Competitors Frenkel Topping Group Competitors Contango Competitors Two Shields Investments Plc (TSI.L) Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors Minoan Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SAR) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAR Stock Alerts